Chiara Scaramuzzino

Dr. Chiara Scaramuzzino

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
AVAmandine Virlogeux
Amandine Virlogeux
CSChiara Scaramuzzino
Chiara Scaramuzzino
SLSophie Lenoir
Sophie Lenoir
RCRémi Carpentier
Rémi Carpentier
MLMorgane Louessard
Morgane Louessard
FSFrédéric Saudou
Frédéric Saudou
Restoring huntingtin-mediated intracellular trafficking rescues Huntington disease mice.

6 December 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
AEAviel Even
Aviel Even
GMGiovanni Morelli
Giovanni Morelli
LBLoïc Broix
Loïc Broix
CSChiara Scaramuzzino
Chiara Scaramuzzino
STSilvia Turchetto
Silvia Turchetto
LNLaurent Nguyen
Laurent Nguyen
The axonal transport of vesicles promotes microtubule acetylation across species.

1 April 2021 in Cell Reports
Verified
Journal Article
Open access
AMAlice Migazzi
Alice Migazzi
CSChiara Scaramuzzino
Chiara Scaramuzzino
EAEric N. Anderson
Eric N. Anderson
DTDebasmita Tripathy
Debasmita Tripathy
IHIvó H. Hernández
Ivó H. Hernández
MBManuela Basso
Manuela Basso
The huntingtin (HTT) protein transports various organelles, including vesicles containing neurotrophic factors, from embryonic development throughout life. To better understand how HTT mediates axonal transport and why this function is disrupted in Huntington’s disease (HD), we study vesicle-associated HTT and find that it is dimethylated at a highly conserved arginine residue (R118) by the protein arginine methyltransferase 6 (PRMT6). Without R118 methylation, HTT associates less with vesicles, anterograde trafficking is diminished, and neuronal death ensues—very similar to what occurs in HD. Inhibiting PRMT6 in HD cells and neurons exacerbates mutant HTT (mHTT) toxicity and impairs axonal trafficking, whereas overexpressing PRMT6 restores axonal transport and neuronal viability, except in the presence of a methylation-defective variant of mHTT. In HD flies, overexpressing PRMT6 rescues axonal defects and eclosion. Arginine methylation thus regulates HTT-mediated vesicular transport along the axon, and increasing HTT methylation could be of therapeutic interest for HD.

7 January 2022 in Science Advances
Verified
Journal Article
Open access
CSChiara Scaramuzzino
Chiara Scaramuzzino
ECEmeline C. Cuoc
Emeline C. Cuoc
PPPatrick Pla
Patrick Pla
SHSandrine Humbert
Sandrine Humbert
FSFrédéric Saudou
Frédéric Saudou
Neurotrophin-bearing endosomes respond to local calcium concentrations to self-direct long-range retrograde transport.

30 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
MCMathilde Chivet
Mathilde Chivet
CMcaterina marchioretti
caterina marchioretti
Marco PirazziniMarco Pirazzini
Marco Pirazzini
DPDiana Piol
Diana Piol
CSChiara Scaramuzzino
Chiara Scaramuzzino
Maria PennutoMaria Pennuto
Maria Pennuto
Polyglutamine (polyQ) expansions in the androgen receptor (AR) gene cause spinal and bulbar muscular atrophy (SBMA), a neuromuscular disease characterized by lower motor neuron (MN) loss and skeletal muscle atrophy, with an unknown mechanism. We generated new mouse models of SBMA for constitutive and inducible expression of mutant AR and performed biochemical, histological and functional analyses of phenotype. We show that polyQ-expanded AR causes motor dysfunction, premature death, IIb-to-IIa/IIx fiber-type change, glycolytic-to-oxidative fiber-type switching, upregulation of atrogenes and autophagy genes and mitochondrial dysfunction in skeletal muscle, together with signs of muscle denervation at late stage of disease. PolyQ expansions in the AR resulted in nuclear enrichment. Within the nucleus, mutant AR formed 2% sodium dodecyl sulfate (SDS)-resistant aggregates and inclusion bodies in myofibers, but not spinal cord and brainstem, in a process exacerbated by age and sex. Finally, we found that two-week induction of expression of polyQ-expanded AR in adult mice was sufficient to cause premature death, body weight loss and muscle atrophy, but not aggregation, metabolic alterations, motor coordination and fiber-type switch, indicating that expression of the disease protein in the adulthood is sufficient to recapitulate several, but not all SBMA manifestations in mice. These results imply that chronic expression of polyQ-expanded AR, i.e. during development and prepuberty, is key to induce the full SBMA muscle pathology observed in patients. Our data support a model whereby chronic expression of polyQ-expanded AR triggers muscle atrophy through toxic (neomorphic) gain of function mechanisms distinct from normal (hypermorphic) gain of function mechanisms.

11 July 2023 in eLife
Verified
Journal Article
Open access
HVHélène Vitet
Hélène Vitet
JBJulie Bruyère
Julie Bruyère
HXHao Xu
Hao Xu
CSClaire Séris
Claire Séris
JBJacques Brocard
Jacques Brocard
FSFrédéric Saudou
Frédéric Saudou
Neurotransmitters are released at synapses by synaptic vesicles (SVs), which originate from SV precursors (SVPs) that have traveled along the axon. Because each synapse maintains a pool of SVs, only a small fraction of which are released, it has been thought that axonal transport of SVPs does not affect synaptic function. Here, studying the corticostriatal network both in microfluidic devices and in mice, we find that phosphorylation of the Huntingtin protein (HTT) increases axonal transport of SVPs and synaptic glutamate release by recruiting the kinesin motor KIF1A. In mice, constitutive HTT phosphorylation causes SV over-accumulation at synapses, increases the probability of SV release, and impairs motor skill learning on the rotating rod. Silencing KIF1A in these mice restored SV transport and motor skill learning to wild-type levels. Axonal SVP transport within the corticostriatal network thus influences synaptic plasticity and motor skill learning.